Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Compass Therapeutics Inc (NQ: CMPX ) 1.540 +0.030 (+1.99%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Compass Therapeutics Inc Compass Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference January 07, 2022 From Compass Therapeutics, Inc. Via Business Wire Compass Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference November 22, 2021 From Compass Therapeutics, Inc. Via Business Wire Compass Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update November 12, 2021 From Compass Therapeutics, Inc. Via Business Wire Compass Therapeutics Announces Pricing of Approximately $125 Million Public Offering of Common Stock and Uplisting to Nasdaq Capital Market November 01, 2021 From Compass Therapeutics, Inc. Via Business Wire Compass Therapeutics Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market November 01, 2021 From Compass Therapeutics, Inc. Via Business Wire Compass Reports the Advancement of CTX-009, a Bispecific Antibody, to Phase 2a Development in Patients with Biliary Tract Cancers (BTC), and the Clearance of a Key Clinical Hurdle November 01, 2021 From Compass Therapeutics, Inc. Via Business Wire CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics October 08, 2021 From Compass Therapeutics, Inc. Via Business Wire Compass Therapeutics and ABL Bio Announce Presentation of CTX-009 Clinical Data as a Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics October 01, 2021 From Compass Therapeutics, Inc. Via Business Wire Compass Therapeutics to Present at the Citi 16th Annual Biopharma Virtual Conference August 13, 2021 From Compass Therapeutics, Inc. Via Business Wire Compass Therapeutics, Inc. to Acquire TRIGR Therapeutics, Inc. May 13, 2021 From Compass Therapeutics, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.